Compounders Research Compare

Benitec Biopharma Inc.(BNTC)

Biotechnology · Hayward, CA

$9.00-0.23 (-2.49%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Benitec Biopharma Inc.

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Hayward, CA

24 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jerel A. Banks

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T21:31:07.878Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:31:07.878Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 309,188,700
TTM free cash flow · period ending 2026-06-30: -17,083,870

FMP input reference: 16291309013886a388882617e5d80f34fb5e9972494eca64a5e5fc74bed8c75f

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BNTC Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

BNTC Competitors' Price/FCF Ratio

Benitec Biopharma Inc.

Current

Market Cap

$309.19M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Agenus Inc.

Market Cap

$311.90M

Price/FCF Ratio

N/A

TTM Avg

114347.68

3Y Avg

114347.68

5Y Avg

114347.68

C4 Therapeutics, Inc.

Market Cap

$318.43M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Sanara MedTech Inc.

Market Cap

$321.76M

Price/FCF Ratio

71.44

TTM Avg

796.59

3Y Avg

1526.97

5Y Avg

1526.97

Avita Medical Inc.

Market Cap

$322.71M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CapsoVision, Inc.

Market Cap

$324.76M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Indaptus Therapeutics, Inc.

Market Cap

$293.30M

Price/FCF Ratio

N/A

TTM Avg

2.52

3Y Avg

2.52

5Y Avg

2.52

Mobia Medical, Inc. Common Stock

Market Cap

$292.59M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cabaletta Bio, Inc.

Market Cap

$329.37M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Larimar Therapeutics, Inc.

Market Cap

$288.79M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Benitec Biopharma Inc. (BNTC)	$309.19M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$311.90M	N/A	114347.68	114347.68	114347.68
C4 Therapeutics, Inc. (CCCC)vs ›	$318.43M	N/A	N/A	N/A	N/A
Sanara MedTech Inc. (SMTI)vs ›	$321.76M	71.44	796.59	1526.97	1526.97
Avita Medical Inc. (RCEL)vs ›	$322.71M	N/A	N/A	N/A	N/A
CapsoVision, Inc. (CV)vs ›	$324.76M	N/A	N/A	N/A	N/A
Indaptus Therapeutics, Inc. (INDP)vs ›	$293.30M	N/A	2.52	2.52	2.52
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$292.59M	N/A	N/A	N/A	N/A
Cabaletta Bio, Inc. (CABA)vs ›	$329.37M	N/A	N/A	N/A	N/A
Larimar Therapeutics, Inc. (LRMR)vs ›	$288.79M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics